Thursday, October 17, 2024
YASOPRS Eye Openers
7:01 |
Rapidly progressive orbital compartment syndrome from ischemic reperfusion injury and rhabdomyolysis. |
7:05 |
Clinical characteristics, evaluation, management, and prognosis of primary eyelid Merkel cell carcinoma: A systematic review |
7:09 |
Diagnostic value of Platelet-to-Lymphocyte and Monocyte-to-Lymphocyte Ratios in Differentiating Idiopathic Orbital Inflammation From Orbital Infectious Disease |
7:13 |
Intraoperative Titration of Eyelid Height and/or Contour during Sutureless Conjunctiva-Sparing Mullerectomy |
7:17 |
Triangular Anterior Lamellar Optimization Flap for Wedge Resection Repairs of Eyelid Colobomas |
7:21 |
Q and A |
7:30 |
Orbital Arteriovenous Fistula Treated with “Altitude Therapy” |
7:34 |
A large-language-model trained using the ASOPRS Oculofacial Plastic Surgery Education Center web textbook |
7:38 |
Pickleball-Related Eye Injuries Presenting to United States Emergency Departments, 2010-2023 |
7:42 |
An Analysis of 333 Space-Occupying Lesions of the Orbit at a Comprehensive Pediatric Cancer Center |
7:46 |
Insurance Status Impacts the Rate of Orbital Fracture and Eyelid Laceration Repair |
7:50 |
Q and A |
Oncology Session
8:03 |
Gamma knife radiosurgery versus radiotherapy for primary optic nerve sheath meningioma: outcomes, complications and prognostic factors. |
8:08 |
Atypical imaging characteristics in patients with epithelial tumors of lacrimal gland |
8:13 |
Immune Checkpoint Inhibitors for Periocular Squamous Cell Carcinoma with Perineural Spread into Orbit and Skull Base |
8:18 |
Culprits beside the sun: basal cell carcinoma of the face and eyelid A National Institutes of Health All of Us Research Program Study |
8:23 |
Mohs Micrographic Surgery with Immunohistochemistry for Periocular Melanoma In-Situ |
8:28 |
Association between Neighborhood Deprivation and Periocular Skin Cancers Treated with Mohs Micrographic Surgery |
8:33 |
Comparison of Different Treatment Modalities for Periocular Cutaneous Squamous Cell Carcinoma with Perineural Spread. |
8:38 |
Q and A |
ASOPRS Foundation Update and Michael J. Hawes Lecture
8:55 |
|
ASOPRS Foundation Update and Dedication of lecture to Jonathan Dutton, M.D.
|
8:59 |
Eric Steele, M.D. |
Introduction of Geoffrey Tabin, M.D. |
9:02 |
|
“ Impossible dreams - the East face of Mt. Everest and eradicating world blindness”
|
9:45 |
|
|
9:50-10:20 am Break with Exhibitors
Orbit Session
10:21 |
A paradigm shift in Congenital Orbital Teratoma: Globe Preserving surgery vs. Exenteration |
10:27 |
Ophthalmic Outcomes of Transorbital Skull Base Surgery |
10:33 |
Necrobitic Xanthogranuloma : Clinical Presentation and Management in a Single Center |
10:39 |
Factors Predicting Mortality and Skull Base Involvement in Patients with Invasive Fungal Sino-Orbital Disease |
10:45 |
Corneal Neurotization for Neurotrophic Keratitis in Congenital Trigeminal Aplasia: A Case Series |
10:51 |
The Use of Dilute Hypochlorous Acid in the Treatment of Periorbital Necrotizing Fasciitis |
10:57 |
Q and A |
Eyelid Session
11:11 |
Laudable Pus, Cocaine, and the Evolution of Wound Closure |
11:17 |
Xanthelasma Palpebrarum is Not Associated with Dyslipidemia or Cardiovascular Disease in a Large Cohort: A Case Control Study |
11:23 |
Single Suture Frontalis Muscle Flap Advancement: A Modified Technique for Congenital Ptosis Repair |
11:29 |
Periorbital Distance Prediction and Disease Classification of Oculoplastic Images Using Deep Learning |
11:35 |
Evaluating AI-Generated Educational Videos for Postoperative Care in Oculofacial Surgery |
11:41 |
Change in Upper Eyelid Contour following Sutureless Conjunctiva-Sparing Mullerectomy |
11:47 |
Q and A |
12-1 pm Lunch, YASOPRS Lunch and Product Theaters
Featured Talk
1-1:02 pm |
Eric Steele, M.D. |
Introduction of Roger Dailey, M.D. |
|
|
"Jones Tubes title TBD" |
1:27-1:35 pm |
|
Q and A |
Thyroid Session
1:36 |
Teprotumumab Treatment for Thyroid Eye Disease-Associated Compressive Optic Neuropathy |
1:41 |
Effect of Smoking in Thyroid Eye Disease: Smokey Fat is a Bulky broken Fat- An Electron Microscopic and Histopathological Study |
1:46 |
Preliminary Safety and Efficacy of Subcutaneous Lonigutamab (Anti–IGF-1R) from a Phase 1/2 Proof of Concept Study in Patients with Thyroid Eye Disease |
1:51 |
VRDN-003, Next-Generation Full Antagonist Antibody to IGF-1R: Two Proposed Randomized Placebo-Controlled Clinical Studies in Patients With TED (REVEAL-1 and REVEAL-2) |
1:56 |
Intravenous steroids versus teprotumumab for the management of thyroid eye disease. Is teprotumumab a game-changer? |
2:01 |
Monocytes express a functional thyrotropin receptor |
2:06 |
Teprotumumab Associated Menstrual Changes |
2:11 |
Orbital decompression in the biologic era: is there a role for surgery? |
2:16 |
Q and A |
Featured Speaker: Aaron Lee, MD
2:30 |
|
Introduction of Aaron Lee, M.D. |
2:32 |
Aaron Lee, M.D. |
"Applications of Deep Learning in Ophthalmology" |
2:55 |
|
Q and A |
3-3:30 pm Break with Exhibitors
3:30-5 Breakouts in Eyelid, Aesthetics, and Orbit
5-6:30 pm Networking Reception
Friday, October 18, 2024
YASOPRS Eye Openers
7:01 |
Patterns and Management of Nodal Metastasis in Patients with Eyelid Sebaceous Carcinoma |
7:05 |
Immune Checkpoint Inhibitor Therapy for Locally Advanced or Metastatic Periocular Merkel Cell Carcinoma |
7:09 |
Pre-operative Onyx embolization of large facial intraosseous hemangioma |
7:13 |
Outcome Comparison of Sphenoid Wing Meningioma Resection with and without Lateral Orbital Wall Reconstruction |
7:17 |
Thyroid stimulating immunoglobulin as a biomarker for thyroid eye disease prognosis following teprotumumab therapy |
7:21 |
Q and A |
7:30 |
Penetrating Transorbital Intracranial Injury Due To Ballpoint Pen |
7:34 |
Secondary Sebaceous Carcinoma in Retinoblastoma Survivors: A Case Series |
7:38 |
Umbilical Amniotic Membrane (AM-UC) as a Skin Substitute in Periocular Reconstruction: A Case Series |
7:42 |
Sutureless Conjunctiva-Sparing Mullerectomy: Pearls and pitfalls from our first 500 cases |
7:46 |
A Case of Orbital Compartment Syndrome without Evidence of Retrobulbar Hemorrhage or Venous Sinus Thrombosis |
7:50 |
Q and A |
Aesthetics Session
8:04 |
Finesse in Forehead Lifting – Asymmetric Release for Asymmetric Ptosis |
8:09 |
Risk of Blindness in Temple Filler Injections: Exploring Vascular Anastomosis from the Deep Temporal Arteries to the Ophthalmic Artery |
8:14 |
Micropigmentation for facial and periocular surgical scar camouflage |
8:19 |
Comparison of the longevity of micro-fat graft in conjunction with each of the products of SVF, ADSC and nano-fat in nude mice model |
8:24 |
Diagnosis and treatment of filler orbital syndrome |
8:29 |
Customized Endoscopic Male Forehead/Eyebrow Lift |
8:34 |
Q and A |
Lacrimal/M&M Session
8:47 |
Long-term Effects of Orbital Lacrimal Gland Resection for Canalicular Obstruction and Functional Epiphora |
8:53 |
Bilateral Corneal Neurotization using the Greater Auricular and Posterior Auricular Nerves |
8:59 |
A Novel Technique for Removal of ‘Hard-to-Find’ Metallic Foreign Bodies in the Posterior Orbit |
9:05 |
Medial Canthal Eccrine Poroma with Invasion of the Nasal Cavity – Excision and Staged Reconstruction |
9:11 |
Multidisciplinary Management of Silent Sinus Syndrome |
9:17 |
Q and A |
9:30-10 am OMIC Risk Management
10-10:30 am Break with Exhibitors
Henry Baylis Lecture
10:30 |
Bob Goldberg |
Introduction of the Henry Baylis Lecturer: Tanuj Nakra |
10:34 |
Tanuj Nakra |
Henry Baylis’ Timeless Insights for Oculofacial Surgeons
|
10:54 |
|
|
10:59 |
Bob Goldberg |
Presentation of the Henry Baylis Cosmetic Surgery Award |
11 am - 12 pm ASOPRS Business Meeting
12-1 pm Lunch, SASOPRS Lunch, YASOPRS Round Tables, and Product Theaters
Practice Management, Ethics and Diversity Session
1:01 |
Inflation-Adjusted Changes in Medicare Reimbursement for Commonly Performed Oculoplastics Procedures Over the Last Decade |
1:07 |
Evaluating Oculoplastics Procedure Waste: A Quality Improvement Study |
1:13 |
The Impacts of Reimbursement Rates on Oculoplastic Procedure Location Choice: A Discrete Choice Analysis |
1:19 |
Ocular Trauma Predicts Poor Outcomes in Patients with a History of Intimate Partner Violence |
1:25 |
The Efficacy of a Midfacial Oxygen Scavenger Mask in Reducing Local Oxygen Concentrations and Oculofacial Surgical Field Fire Risk |
1:31 |
The current landscape of ASOPRS oculofacial surgeons |
1:37 |
Emotional Intelligence, Burnout, and Professional Fulfillment among ASOPRS Attendings and Fellows |
1:43 |
Q and A |
Pediatrics Session
1:56 |
Dacryocystorhinostomy outcomes for congenital nasolacrimal duct obstruction associated with craniofacial abnormalities |
2:02 |
Frontalis suspension for congenital ptosis: Re-operation rate and timing based on age at time of surgery |
2:08 |
Can A Crease Lead the Way? A Single Center Review on Simple Congenital Ptosis Intervention and the Role of Lid Crease Evaluation |
2:14 |
Severe Chalazion Development in Adolescents with Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor |
2:20 |
Medial rectus pyomyositis as a complication of orbital cellulitis: A case report |
2:26 |
Q and A |
2:40-3:10 pm Break with Exhibitors
3:10-4:30 Facelift Panel
Thesis Session
4:31 pm Subperiosteal Abscess of the Orbit: Long-term Trends in Bacteriology and Clinical Outcomes and Current Management Recommendations |
4:35 pm Comparison of kinetic, automated, tangent screen and novel disposable perimetry for the evaluation of dermatochalasis and blepharoptosis |
4:39 pm Award Presentation |
4:40 pm ASOPRS Awards Session
5 pm Adjourn